ClinicalTrials.Veeva

Menu

Suture Versus Glue (Dermabond) Closure During Cesarean Delivery (SVGCS)

Clalit Health Services logo

Clalit Health Services

Status and phase

Unknown
Phase 4

Conditions

Suture; Complications
Adhesive; Band

Treatments

Device: MODIFIED VICRYL PLUS
Device: DERMABOND GLUE

Study type

Interventional

Funder types

Other

Identifiers

NCT02831946
0062-16-MMC

Details and patient eligibility

About

To investigate the effect of intracutaneous suture closure versus Glue (dermabond) closure at cesarean section (CS) on long-term cosmetic and maternal outcome.

Full description

Women undergoing planned CS were randomized to either intracutaneous suture closure or glue closure using a 1:1 allocation algorithm. Participants and outcome assessors were blinded to group allocation. Scar evaluation was performed after two months.

Primary outcome measures were Patient and Observer Scar Assessment Scale (POSAS) summary scores 2 months after surgery. Secondary outcome measures were, duration of surgery, and development of hematoma, seroma, surgical site infection (SSI) or wound disruption.

Data were analyzed according to the intention to treat principle.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant women between 18 and 45 years
  • Elective cesarian section

Exclusion criteria

  • Clinical signs of infection at the time of CS
  • History of keloids and a medical disorder that could affect wound healing
  • Hypersensitivity to any of the suture materials used in the protocol
  • Diabetes mellitus
  • Disorders requiring chronic corticosteroid use or immunosuppression

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

MODIFIED VICRYL PLUS
Experimental group
Description:
The intra-cuticular layer will closed with with VICRYL PLUS suture
Treatment:
Device: MODIFIED VICRYL PLUS
DERMABOND GLUE
Experimental group
Description:
The intra-cuticular layer will closed with with DERMABOND GLUE
Treatment:
Device: DERMABOND GLUE

Trial contacts and locations

1

Loading...

Central trial contact

Reut Ohana; Yair M Daykan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems